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Health and Growth: Causality through Education 
Abstract 
Purpose--The paper theoretically and empirically investigates the impact on human capital 
investment decisions and income growth of lowered life expectancy as a result of HIV/AIDS 
and other diseases.  
Design/methodology/approach--The theoretical model is a three-period overlapping 
generations model where individuals go through three stages in their life, namely, young, 
adult and old. The model extends existing theoretical models by allowing the probability of 
premature death to differ for individuals at different life stage, and by allowing for stochastic 
technological advances. The empirical investigation focuses on the effect of HIV/AIDS on 
life expectancy and on the role of health on educational investments and growth. We address 
potential endogeneity by using various strategies, such as controlling for country specific 
time-invariant unobservables and by using the male circumcision rate as an instrumental 
variable for HIV/AIDS prevalence. 
Findings--We show theoretically that an increased probability of premature death leads to 
less investment in human capital, and consequently slower growth. Empirically we show that 
HIV/AIDS has resulted in a substantial decline in life expectancy in African countries and 
these falling life expectancies are indeed associated with lower educational attainment and 
slower economic growth world wide.  
 Originality/value--The theoretical and empirical findings reveal a causal link flowing from 
health to growth, which has been largely overlooked by the existing literature. The main 
implication is that health investments, that decrease the incidence of diseases like HIV/AIDS 
resulting on increases in life expectancy, through its complementarity with human capital 
investments lead to long run growth. 
Keywords: HIV/AIDS, Africa, life expectancy, growth, overlapping generations. 
JEL classification: I18;I20;O15 
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I. Introduction 
Better health may lead to increased interest in education and education could also give rise to 
opportunities and choices that result in better health. Traditionally, economists have 
emphasized the second aspect of the relationship between health and education. This paper in 
contrast focuses on the impacts of health on education and economic growth. Investigating 
this relationship is especially illuminating in understanding development in Africa, where the 
HIV/AIDS epidemic has greatly reduced life expectancy.  
The objective of this paper is two-fold. First we model theoretically how the 
HIV/AIDS epidemic, through its effects on the probability of premature death, impacts 
educational investment and growth. Then we empirically test the implications of our model 
and quantify the impacts of HIV/AIDS on educational attainment and growth. We develop a 
three-period overlapping-generation model with learning and technology adoption that links 
increased mortality and shortened life expectancy to the human capital investment decisions 
of representative agents. The propositions derived from this model are tested with a series of 
cross-sectional and panel analyses, explicitly accounting for potential endogeneity by using 
the instrumental variable approach based on predetermined variables.  
In the following, we briefly review recent literature. Then we describe the theoretical 
model and report the empirical tests of hypotheses suggested by the model. In addition, we 
examine the effect of HIV/AIDS on life expectancy in African countries using an 
instrumental variable approach. The final part of the paper is a conclusion that summarizes 
the policy implications of the analysis.  
II. Literature  
Most discussions of the relationship between health and education assume that the 
main direction of causality has been from education to health (Grossman,1973). For a 
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comprehensive review of empirical findings, see Grossman and Kaestner (1997). Freeman 
and Miller (2001) expressed surprise at the meagre amount of knowledge about the effects of 
changes in health status on economic growth.  
Only limited research has examined the role of health in economic growth, most of it 
theoretical. Ehrlich and Lui (1991) develop an overlapping-generations model of endogenous 
growth in which human capital is the engine of growth and the generations are linked through 
material and emotional interdependencies within the family. Swanson and Kopecky (1999) 
studied the effect of increasing life expectancies on human capital accumulation finding that 
increasing length of life not only encourages individuals to invest in more education prior to 
entering the work force but also to continue acquiring new knowledge and skills as adult 
workers.   Kalemli-Ozcan, Ryder and Weil (2000) studied the relation between increased life 
expectancy and human capital investment during periods of economic growth in a continuous 
time, overlapping-generations model. They find that increasing life expectancies give rise to 
greater demand for education as well as increased consumption of other goods. Technology is  
assumed, however, to be stagnant in their model. Bils and Klenow (2000) investigate the 
empirical correlation between growth and education and suggest that part of the correlation 
between schooling and growth is accounted for by the effect of growth on education. 
Kalemli-Ozan (2002) analyzed theoretically the effects of declining mortality rates on 
fertility, education, and growth. She finds that economic growth is promoted as a result of 
declining mortality. Bloom and Canning (2000, 2005) argue that health is a form of human 
capital and therefore an input into the growth process, as well as an output.  They find from 
their model that, improvements in longevity lower fertility, raise educational investment, and 
raise the long run growth rate of output.  Bell et al. (2006) also examined the effect of an 
AIDS-type increase in premature adult mortality on the inter-generational transmission of 
human capital. Based on an over-lapping generation model, they show that an otherwise 
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growing economy could decline to a low-level subsistence equilibrium if hit with an AIDS-
type increase in premature adult mortality.   
There is a growing number of empirical cross-country studies on how HIV/AIDS 
affects macroeconomic variables. Bloom and Mahal (1997) failed to find that HIV/AIDS was 
a significant factor in slower growth rates in African countries during the period 1980-1992, 
when HIV/AIDS was considerably less widespread. In contrast, Bonnel (2000), using more 
recent data, found that this single disease resulted in a reduction in per capita growth in 
Africa of 0.7 percentage points.  McDonald and Roberts (2006) estimate a Solow growth 
model with health and educational capital as well as physical capital and effective labor as 
explanatory variables. They found substantial impacts of HIV/AIDS on health and growth but 
did not find educational capital to be significant in their growth rate equation.  
In this study, we model a particular mechanism through which HIV/AIDS affects 
growth rates, namely, the reduction in investments in human capital that is expected to result 
from lower returns to such investments when life expectancy declines. The theoretical model 
is a discrete-time, overlapping-generation model in which individuals learn from the previous 
generation and make schooling investment decisions, knowing that the human capital 
acquired from educational investments will facilitate technological adoption in a later period.  
Our theoretical model departs from the previous work in three important ways. First, 
we build an extra period into the usual two-period overlapping generation model, which 
allows us to model the varying probability of premature death in human life cycles and the 
successive decisions of investing in education when one is young and adopting technologies 
when one starts to work. This is important for HIV/AIDS as HIV/AIDS tends to affect the 
life expectancies of children and adults in different ways. Secondly, human capital is two-
dimensional in the model, reflecting both its quality and ease of adoption. Thirdly, the model 
includes exogenous technological advances. 
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The results show that a higher probability of premature death will reduce investment 
in human capital. This reduced investment means that economic growth is lower even though 
the rate of technical innovation is unchanged. We test the implications of the theoretical 
model in two steps. First, we test whether shorter life expectancy or higher probability of 
premature death leads to a decline in human capital investment and economic growth with 
both cross-sectional and panel regressions. In specifying the regression equations, we use 
health variables from 25 years ago that correspond to the health level when the current 
generation started to make lifetime human capital investment decisions. This approach also 
circumvents the potential endogeneity problem that would arise if current health variables are 
used. Second, we focus on African countries and examine how life expectancy in Africa is 
affected by the HIV/AIDS pandemic. We use the male circumcision rates compiled by Ahuja, 
Wendell, and Werker (2007) as instrumental variables to deal with the endogeneity of 
HIV/AIDS prevalence rates and life expectancy. The results clearly show that a falling life 
expectancy has significant adverse effects on human capital investment and the economic 
growth rate.  
III. A Three Period Overlapping Generations Model. 
Kim and Lee (1999) analyze the effects of technology change on growth rates of income and 
human capital. Their model includes two dimensions of human capital, referred to as width 
and depth. Human capital width represents flexibility, adaptability, and the influence of 
human capital on the adoption of new technologies. Width determines the adoption cost of a 
new technology. Human capital depth measures the quality of the human capital stock. They 
find that an increase in technological uncertainty decreases growth rates of income and 
human capital by lowering efficiencies both in creating new knowledge and in adopting new 
technologies.   
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In studying the impacts of health on educational investments, we extend Kim and 
Lee’s model to three periods and introduce the probability of dying prematurely. The 
extension to a third period can be justified by the likelihood that the probability of death is 
not constant throughout an individual’s life as shown by  Kalemi-Ozcan, et al. (2000).  In 
addition, there is abundant empirical evidence that AIDS results in higher probabilities of 
dying for young adults who are more sexually active than for other age groups. Hence we 
build a three-period model to allow for different age-specific probabilities of dying. 
 In this model, a representative agent lives at best for three periods, referred to as 
youthful, adult and mature. When young, the agent divides her time between work and 
education. As an adult, she allocates her available time to work and technology adoption. 
When mature, she devotes all of her time endowment to working.  
The agent faces a probability of dying at the end of the 1st period and 2nd period, denoted 
by PY and PA respectively.  The relationship between the two probabilities is 
)1(*
)1()/2(1)1(
Y
YA
PP
PtltlPP
−⋅=
−⋅≥≥=−
 
where l denotes life expectancy of the agent, t denotes one period of time, P* denotes the 
conditional probability of surviving to the end of the second period if the agent doesn’t die at 
the end of first period. Note that if P*=0, the agent lives two periods at most.  
A new and advanced technology A is assumed to occur with a probability of p in each 
period. New technologies may differ in their characteristics. It is assumed that potential 
technologies can be arrayed along a continuum running from 0 to S and that a new 
technology might occur with characteristics that place it anywhere on this continuum.   
Adult agents may adopt a new technology when a technology shock occurs. An agent 
may have several ‘knowledge points’ distributed along the technology space [0, S]. To adopt 
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a new technology, the agent must have a knowledge point located close to the point in [0,S] 
which characterizes the technological innovation. The more knowledge points an agent has, 
the more likely it is that the technological innovation will lie close to one of his knowledge 
points, reducing the cost of adoption. 
The initial structure of the agent’s human capital consists of two dimensions: width 
and depth. Width is represented by the number of knowledge points, N, possessed by the 
agent in the interval [0,S]. The greater the width, the more knowledge points the agent has 
and the more likely it will be that the technological innovation will be adopted. Depth 
represents the quality of human capital. It is assumed that the depth of an agent’s human 
capital determines the level of technology that can be adopted. The agent cannot adopt a new 
technology if it is beyond the depth of her human capital, Q.  
An agent is assumed to need time (lA) to realize the technology adoption:  
AsxalA ||)2( −=  
where a, the adoption cost, is a parameter indicating adoption efficiency, s denotes the 
location of an agent’s knowledge point closest to point x  in [0,S] which characterizes the 
innovation. The technical adoption, thus, requires more time as the level of the technology 
increases and as the distance between an agent’s own knowledge point and the location of the 
technology on [0,S] increases. Because the agent’s human capital depth determines the level 
of technology she can embrace, the adoption time can be written as 
QsxalA ||)'2( −=   
To minimize expected adoption cost, the N knowledge points must be uniformly 
distributed over the knowledge space. The reason equal spacing represents the best strategy is 
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because the characteristics of a technical innovation is a random variable uniformly 
distributed on the technological space [0,S].  
After an adult agent adopts a new technology with a level of quality of Q, the depth or 
quality of the agent’s human capital becomes Q.  
tat QH =)3(  
where Hat is the human capital stock of an adult at time t and Qt is the agent’s depth of human 
capital at period t. It is also assumed that there are spillover effects so that a certain fraction 
of the technology, once adopted and in use, can also be used by young agents without cost. 
Therefore, the young agents’ specific human capital at time t becomes 
QHyt δ=)4(
 
where Q  denotes the current adult generation’s amount of specific human capital and 
10 ≤δ< , is the spillover effect. 
A youthful agent invests an amount of time lE in education and builds his human capital stock 
of NQ:  
NQlbQN Ett ⋅⋅=)5(  
where lE is the time the youthful agent devotes to education and NQ  is the human capital 
owned by the current adult generation. The parameter b captures the efficiency of the elder 
generation in passing its knowledge to the next cohort. This specification implies that 
youthful agents accumulate education by spending time in school and paying tuition to the 
adults if no new technology occurs for the current adult generation to compensate for the 
instructors’ opportunity cost. Here we assume that only the individuals with the highest 
available depth of human capital in a period can be instructors. 
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  The next step is to determine the human capital stock of a mature agent. If the 
current mature agent adopted technology in his adult period and no new technology occurs 
during the period when he is mature, his human capital stock defines the highest level of 
human capital of the society. We therefore assume his human capital to be Q)1( 1τ− , where 
τ1 is a depreciation rate in [0,1].  If he adopted in his adult period, but new technology occurs 
when he is mature, his human capital stock becomes Q)1( 2τ− , where 12 ττ < is also a 
depreciation rate. If he had not adopted technology as an adult, but new technology occurred 
in his mature period, then he, like the youthful agent, enjoys a spillover effect from the 
human capital of the current adult. If no new technology occurred in either his adult or 
mature period, all three generations have to share the human capital stock that spilled over 
from the cohort that has passed away, i.e., Qδ .  If new technology does not occur in his adult 
period but does occurs in his mature period, his human capital is also the spillover effect of 
the current adult generation, Qδ . It is assumed that the spillover effect is not as large as the 
individual’s own human capital (depreciated). Therefore, the agent is always better off 
adopting his own new technology whether his technology is outdated by new technology or 
not.  
The representative firm employs youthful, adult and mature workers together. The input 
is human capital only, and the technology is linear, which implies that the human capital of 
each of the three generations is a perfect substitute for that of the others: 
(6) (1 ) (1 )t yt E at A mty H l H l H= ⋅ − + ⋅ − +  
where yt is the total output of the economy at period t, Hyt is the human capital possessed by 
the young generation at period t, Hat and Hmt are that of the adult and mature generations 
respectively. A representative young agent’s maximization problem on the width and depth 
of her human capital is: 
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where U is lifetime expected utility, which depends on consumption in the three periods, 
respectively denoted by cyt, cat and cmt . The solutions from the above equation for Q and N 
are given by (see Appendix 1 for details): 
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Pk , and z* is the equilibrium ratio of depth to width given the 
characteristic space of the innovation that has occurred. It is a constant between [0.42, 0.2] 
and it declines as k increases. 
 The comparative static results are: 
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In equilibrium, N, Q and income grow at the same rate.  In this economy, only adults adopt 
new technology, therefore, all growth in production comes from the current adults’ human 
capital stock compared with their human capital stock in the youthful period. The equilibrium 
is a balanced growth path. In particular, 1N Q y g
N yQ= = = + , where g is the growth 
rate with technological advance, i.e., the income growth of an adult (relative to his youth) if 
he adopts a new technology. From Equation (5), the education time of young agents is 
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. Putting this expression into the first-order conditions of 
the maximization problem, we have  
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It is easy to see that the growth rate increases with the probability of surviving the 
youthful period (1- Py ) and with the conditional probability of living through the three 
periods if one survives the youthful period P*.  The expected growth rate of output is,  
2
1
(1 4 ) (1 ) (1 ) { [1 * (1 ) ]
2 (1 ) (1 ) [1 * (1 ) ] }
yE g P p p g P
p p p g P
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δ τ
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The expected adoption time is therefore: 
0
(1 ) (1 )(15) ( ) (1 *)
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Since (1-z*) increases with the conditional probability of living to the mature period if 
the individual survives the youthful period (P*) then the adoption time increases with the 
increases in probability of technological advance (p), the probability of surviving the youthful 
period (1-Py) and the conditional probability of living through the three periods if one 
survives the youthful period (P*). Thus the growth rate of income decreases as the 
probability of premature dying increases. Equation (14) and equation (10) provide the main 
theoretical implications of this model:   
 
 
1. The income growth rate increases with higher life expectancy. Therefore, there can be 
persistently different growth paths for countries with different life expectancies, even if the 
occurrence of technological progress is the same for all the countries. This dimension of the 
relationship between health, human capital investments and growth may be more significant 
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in places such as Sub-Saharan Africa where the HIV/AIDS pandemic may lead to severe 
reductions in life expectancy.   
2. Adoption time increases with the increases in the probability of technological advance, the 
probability of surviving the youthful period, and the conditional probability of living through 
the three periods if one survives the youthful period. Therefore the growth rate of income 
decreases as the probability of premature dying increases, establishing the main result of this 
paper.  Note that the immediate effect of an epidemic or a persistent war that drastically 
shortens people’s life expectancy is to reduce income due to loss of labor. These effects are 
not discussed in the model. Rather, our results show that in long-run equilibrium, slower 
growth results from a reduction in individual investments in human capital due to a shorter 
life span.  
III. Empirical Analysis 
The empirical section of this study is relevant to the broader literature on the impact of health 
on education and income. At the macroeconomic level, it is not clear whether causality runs 
from health to increased wealth, the reverse, or in both directions. Although many believe 
that improving health leads to increased wealth and economic growth (e.g. World Health 
Organization, 2001; Bloom and Canning, 2005; Weil, 2005), Acemoglu and Johnson (2006) 
suggest that improving health may have a negative impact on GDP per capita because 
increased life expectancies lead to larger total populations and lower per capita income unless 
the population growth is matched by per capita productivity increases. This study also 
contributes to an understanding of one of the prominent debates in the literature on the 
economic impacts of the HIV/AIDS pandemic.  On one hand, HIV/AIDS reduces the current 
human capital stock because it predominantly affects adults and, as we will argue, it also 
decreases the incentives for the young to invest in human capital, thereby decreasing income.  
On the other hand, the pandemic might increase income per capita through positive pressure 
on wages (Young, 2005).  
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The theoretical section stresses a channel largely ignored by previous research 
through which HIV/AIDS or other epidemics could affect growth. We showed in a three-
period overlapping-generations general-equilibrium model that a decrease in life expectancy 
will result in a reduction in human capital investment and consequently a lower growth rate. 
It is worth noting that although we are especially interested in understanding the 
consequences of the HIV/AIDS epidemic for income growth in Sub-Saharan Africa, the 
implications of our theoretical model go beyond HIV/AIDS extending to other health 
conditions or even political conditions that may lower life expectancy significantly in a 
population or in a sub-population. Moreover, the existence of such a channel does not 
necessarily mean that we will find statistically significant effects of HIV/AIDS on growth or 
reduction in education, because the theoretical model does not include many other socio-
economic factors and mechanisms that can potentially reinforce or offset the causal effects of 
HIV/AIDS on human capital investment. On the other hand, there are other channels through 
which HIV/AIDS might affect human capital investment and therefore growth. For example, 
if treating HIV/AIDS exhausts a family’s financial resources, then HIV/AIDS will result in a 
reduction in human capital investment even if education is still deemed desirable. The 
purpose of the empirical analysis is to explore whether HIV/AIDS affects life expectancy and 
whether decreased life expectancy leads to a reduction in human capital investment. Because 
of the significance of other factors, however, the results of the empirical analysis can only be 
interpreted as suggestive.  
Our empirical strategies are the following. In the reduced form regression and 
working at the country level of aggregation, we first establish the relationship between 
probabilities of premature death and human capital formation and then we examine how 
HIV/AIDS/ has affected these probabilities.   
The data set for this analysis is a country panel compiled from several sources. Data 
on the prevalence of HIV/AIDS are from the CIA World Fact Book (2007) which includes 
2001 and 2003 estimates for 168 countries. Information on income, education and general 
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health indicators is from both the World Bank’s 2006 World Development Indicators 
(WDI) database and a database developed by Barro and Lee (2000).  In Table 1 we list the 
source of each of the variables used in the regressions. Male circumcision rates compiled by 
Ahuja, Wendell, and Werker (2007) are used as instruments to establish the link between 
HIV and general health. The specific countries included in each of the regressions are listed 
in Table 7. 
(1) Impact of Health on Education Attainment 
The theoretical model is based on the distinction between human capital depth and 
width. There are no empirical measures of these dimensions of human capital so this analysis 
relies on more broadly defined human capital measures, such as years of education (Barro 
and Lee, 2000). The number of years of education could be taken to represent human capital 
depth. One of the behavioral relationships from the model described above (equation (A9) in 
appendix) establishes that the time an agent devotes to education and technology adoption is 
negatively related to her probability of dying prematurely.  
We specify the following panel regression to examine the effect of the probability of 
premature death on educational attainment: 
,( 25) 0 ,( 25)(16) log( )i t it it i i i tEduc Educ Health X Cα α β γ θ ε+ += + + + + +   
where 
,( 25)i tEduc +  is country i ’s average schooling years in the  total population over 
age 25 in the year of 1985, 1990, 1995 and 1999, and itEduc  is the same variable 25 years 
ealier, or roughly one generation earlier, in the year 1960, 1965,1970, and 1975. 
log( )itHealth  is the logarithm of the country’s health indicator 25 years earlier.  We adopt 
three alternative health indicators, namely, infant mortality rate, life expectancy at birth and 
crude death rate. iX  is a vector of country specific covariates that can affect education, 
including  the logarithm of GDP per capita 25 years earlier, the interaction term between it 
and the health indicator, and measures of openness and investment 25 years earlier. The 
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inclusion of these covariates controls for initial differences among the countries, other than 
the initial level of education that will affect the efficiency of the younger generation’s 
learning process.  iC  is the country-specific fixed effect used to control for time-invariant 
country-specific heterogeneity, such as geography, climate and culture. In effect, the country 
fixed effects and country-specific covariates are proxies for the parameter b in the theoretical 
specification. 
The regression results are reported in Table 2. The results are consistent with the 
hypothesis that the probability of premature death, as reflected by the infant mortality rate, 
the crude death rate and life expectancy at birth, has a highly significant negative impact on 
human capital investment. Although the signs are the same as the cross-sectional results, the 
magnitudes of the coefficient estimates in the panel regressions are larger.    
(2) Health impact on income growth 
The theoretical model indicates that an increase in the probability of premature death 
will slow income growth through its effects on human capital investment. In this section we 
examine whether and to what degree the income growth rate is affected by health. The 
estimated equation does not provide direct evidence related to the hypothesis because we are 
not able to isolate the effect of health on income growth solely through its impact on human 
capital investments. Rather, this exercise will capture the net effect of health on income 
growth, whether through human capital investment or through other channels. Both cross-
sectional and panel data regressions of the various health indicators on the GDP per capita 
growth rate were estimated.  
Similar to the regression of educational attainment on health, the dependent variables 
are the logarithm of the per capita GDP growth rate during the periods 1960-1985, 1965-
1990, 1970-1995, 1975-2000, and 1980-2005. The explanatory variables are the same as in 
the regressions for educational attainment. Specifically, the independent variables are the 
logarithms of the three health measures, the logarithms of GDP per capita in constant 2000 
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dollars, and the logarithms of the net secondary enrollment rate from the World Bank2 for 
the years 1960, 1965, 1970, 1975 and 2000. We use country fixed effects to control for 
country-specific heterogeneity. Table 3 shows the results. The growth rates are negatively 
correlated with initial GDP per capita, and also initial education levels. A plausible 
explanation for this is that the growth rates of high-income economies are slower than those 
of lower-income countries because of convergence. There is also the possibility of 
simultaneous equations bias as education and income might be simultaneously determined. 
Using initial education and initial income as controls, the results show that the healthier 
countries are growing faster than countries with poorer health. Specifically, a one percent 
increase in the infant mortality rate or the crude death rate at the beginning of the period 
reduces the growth rate of income by about a half percentage point. In summary, we have 
found empirical evidence using panel regressions that initial health contributes significantly 
to the growth rate of income in subsequent periods. This indirectly supports the theory, as 
established in equation (14) that an increase in the probability of premature death leads to 
slower income growth due to a reduction in incentives for human capital investments.  
(3) The Effect of HIV/AIDS on life expectancy or mortality 
Sub-Saharan Africa has been particularly affected by the HIV/AIDS pandemic and 
has seen a dramatic decline in life expectancy, notably in the countries in the southern cone. 
According to a UN report on population and AIDS (2005), a child born in Zimbabwe, where 
about a quarter of the adult population is living with HIV, would have a life expectancy of 64 
if there had been no HIV/AIDS pandemic, but of only 37 given the actual prevalence of 
HIV/AIDS.  
Using the data provided by this UN report, we plot in Figure 1 the difference in life 
expectancy at birth of the African countries with and without AIDS against the HIV 
prevalence rate.  The strong relationship between HIV/AIDS prevalence and life expectancy 
                                                 
2
 We use the secondary enrollment rate as a proxy for education instead of Barro & Lee’s average schooling 
years because the information is available for more countries than the Barro & Lee measure.  
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reduction is clearly shown. Although Figure 2 shows a clear relationship between life 
expectancy and HIV prevalence rates, it does not identify causality, or the direction of 
causality. More specifically, we have to deal with potential endogeneity or reverse causality 
problems in our investigation of HIV/AIDS effects on health outcomes. Reverse causality 
arises when the causality flows from health outcomes to HIV/AIDS prevalence, and 
endogeneity arises when health outcomes and HIV/AIDS prevalence rates move together due 
to a third variable, such as income.  
[Figure 1 inserted here] 
To address these two indentification issues, we adopt an instrumental variable 
approach. A valid instrumental variable should be correlated with the HIV/AIDS prevalence, 
but uncorrelated with unobservable variables. Such a valid instrument overcomes the 
endogeneity issue by isolating the variation in HIV/AIDS prevalence rates due to exogenous 
variation in the instrumental variable. We follow Ahuja, Wendell and Werker (2007) and use 
male circumcision rates as our instrumental variables.  
To explore the relation between life expectancy in Sub-Saharan Africa and the 
incidence of HIV/AIDS, we use panel data for 38 African countries in the years 1980, 1985, 
1990, 1995, 2000 and 2004. Information on the prevalence of HIV in the early years of the 
pandemic is sparse. In addition, according to Donnelly (2004), UNAIDS has revised some of 
its estimates of the incidence of HIV in Africa in light of new information. An original 
estimate that 15.0 percent of adults in Kenya were HIV positive was subsequently revised 
down to 9.3 percent in 2004 after it was discovered that a 2003 household survey showed 
HIV prevalence as low as 6.7 percent. Donnelly reported that UNAIDS bases its estimates on 
the best available information and frequently revises them as more complete information 
becomes available. Because UNAIDS advises against comparing HIV/AIDS prevalence 
estimates of different years directly (UNAIDS,2008), we use a single-year observation of 
HIV prevalence, interacted with a year dummy, as a proxy for the actual HIV/AIDS infection 
rates in the sample countries. Ahuja, Wendell and Werker (2007) used 1997 infection rates 
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but we have chosen to use more recent observations, 2001 or 2003 depending on which 
year is available in the CIA World Fact Book 2007. Interaction terms between this infection 
rate and dummy variables for 1990, 1995, 2000, and 2004 are included to reflect the rapid 
spread of the pandemic during those years (see Ahuja, Wendell and Werker (2007)).  It is 
assumed that the HIV infection rate was zero for 1980 and 1985.  
The following system of equations is estimated: 
1
2 3 4
1 2 3
4
(1 6 ) 1 9 9 0
1 9 9 5 2 0 0 0 2 0 0 4
1 9 9 0 1 9 9 5 2 0 0 0
2 0 0 4
i t i t i t
i t i t i t
i t i t i t
i t i t
L a b h i v
h i v h i v h i v
X X X
X
β
β β β
γ γ γ
γ ε
= + +
+ + +
+ + +
+ +
                          
where itL is life expectancy in year t in country i, ia  and tb are the country and year 
intercept effects, ihiv  is the CIA  HIV prevalence rate estimate for country i  in 2001 or 2003, 
iX  is a vector of country specific control variables, including initial life expectancy and 
initial GDP per capita. All right hand side variables are interacted with years so that different 
slope effects are obtained for each year. The last term is a stochastic error. We use male 
circumcision rates compiled by Ahuja, Wendell and Werker (2007) as an instrument for the 
prevalence of HIV. Though it is not entirely clear through what mechanism a higher male 
circumcision could reduce HIV prevalence, the medical literature has established a causal 
effect of male circumcision rate on HIV prevalence, through three randomized trials in three 
African countries, namely, South Africa (Auvert et al. 2005), Kenya (Bailey et al. 2007) and 
Uganda (Gray et al. 2007). In fact, the World Health Organization and UNAIDS 
recommended that an important strategy for the prevention of heterogsexually acquired HIV 
is to promote male circumcision rates (UNAIDS/WHO 2007). Male circumcision rate 
exhibited a high degree of variation across countries in the Africa, and the variation seems to 
be associated with religious, linguistic and cultural differences across these countries. 
 19 
Breirova (2002) also uses circumcision rates as instruments to examine the impact of AIDS 
on education in Kenya.  
In order to show that male circumcision is a valid instrument, one still has to 
determine that it is uncorrelated with the error term in the regression that might cause HIV 
prevalence and health outcomes to move together. Although it is not possible to check 
whether male circumcision rates are correlated with all possible omitted variables, we can 
check whether they are correlated with some of the most important omitted variables which 
are generally considered as preconditions for country level health, such as initial income, 
initial health status, and initial education at country level.  
We plot out these important economic preconditions against male circumcision rate as 
compiled by Ahuja, Wendell and Werker (2007) in Figure 2, Figure 3 and Figure 4.  
[ Figure 2, Figure 3, Figure 4 inserted here.] 
From these plots, there is no obvious correlation between these initial economic and 
health preconditions and male circumcision rates. Therefore, we conclude that the male 
circumcision rate can serve as a valid instrument in the regression equation (16).   
Table 5 summarizes findings from this instrumented fixed-effect panel regression of 
life expectancy on HIV prevalence rate. We also report OLS and random effects two-stage 
least squares estimates for this relationship. The first stage F statistics of the instrumental 
variable regressions are more than 20, indicating that the instruments are not weak. The 
instrumented coefficients have smaller standard errors and larger magnitudes than the same 
coefficients estimated with OLS. The estimates seem robust as there is not much difference 
between estimates with the fixed effects and those with random effects.3 Generally, higher 
HIV infection rates have a negative effect on life expectancy. As time goes by, the effect 
becomes more and more prominent. For example, in the fixed effect instrumented regression, 
                                                 
3
 The fixed effects model treats the differences across countries as parametric shifts of the regression functions 
while the random effects model views individual specific constant terms as randomly distributed across 
countries. Hence the fixed effects model might only apply to the countries in the sample while the random 
effects model would be appropriate if we believe that the countries were drawn from a large population (e.g., 
Green, 2000).  
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a 1% increase in the incidence of HIV decreases life expectancy by 0.3 years in 1990 and 
by one year in 2005.  
In conclusion, we have linked HIV/AIDS prevalence with educational outcomes and 
GDP growth in two steps4. We first showed that variables representing the probability of 
premature death have negative impacts on human capital investment as well as GDP growth 
using panel evidence. Then we established the link between the HIV/AIDS pandemic and life 
expectancy with instrumented regressions. The message is clear: HIV/AIDS leads to lower 
life expectancy or higher probability of premature death and lower life expectancy means that 
people are less likely to invest in human capital with the result that the country ends up with 
less human capital and slower economic growth in the long run.  
IV. Conclusions 
The empirical results reported in the preceding section are consistent with the analytical 
results derived from the overlapping-generations model. While it would be interesting to 
estimate an empirical model that more directly measures the impact of HIV/AIDS on 
economic growth, the lag between the effects of the disease on growth and the incidence as 
reflected in current data make it impossible to estimate meaningful relationships. 
Nevertheless, the analysis does provide substantial evidence that falling life expectancies in 
Africa as a result of the HIV/AIDS pandemic, as well as the widespread incidence of other 
diseases, is leading to reduced investments in human capital formation which in turn results 
in lower human capital stocks and slower growth. The implications of this result are 
extremely serious. If the spread of HIV/AIDS and other diseases leads to less economic 
growth in African countries, there will be fewer resources in these countries for use in 
combating the diseases. Through the mechanisms identified in this paper, as well as the more 
obvious connections between disease and economic growth, a vicious cycle could develop in 
                                                 
4
 Alternatively, one might consider estimating a system of equations with simultaneous equations on education, 
GDP growth, life expectancy, and HIV prevalence rate. However, for identification there needs to be some 
exogenous variables that are in some of the equations but not in the others so in practice this would be very 
difficult.  
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which disease slows growth reducing the ability to control the disease, which becomes 
more widespread slowing growth even further. 
The Global Fund to Fight AIDS, Tuberculoses and Malaria was established in January 
2002 by the United Nations to focus contributions from wealthy countries on the fight against 
these diseases in low-income countries. According to the internet site for the Fund, some 
$15.6 billion had been disbursed in 140 countries by mid-2009 (The Global Fund, 2009a). 
According to a 2009 Progress Report (The Global Fund, 2009b), these efforts have had 
substantial positive impacts in the fight against these diseases. The proportion of people 
infected by the HIV virus who are receiving treatment, however, is predicted to fall from 31 
percent to 21 percent as the amounts disbursed by the fund fall short of the growing needs. If 
the analysis in this paper is correct, adequate funding and rapid implementation of the Global 
Fund’s programs as well as of other programs targeted at these devastating diseases are 
critical if the vicious cycle described above is to be short-circuited. The nature of HIV/AIDS 
is such that it is very important to undertake effective preventive programs as soon as 
possible in order to avert an explosion of cases in coming years. Reducing the incidence of 
these diseases and raising life expectancies are clearly ends in themselves. But, in addition, 
increased life expectancy has the instrumental value of providing incentives for greater 
investments in the human capital that contributes significantly to economic growth and 
human well-being. 
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Table 1. Variables and Their Sources 
Variables Source 
Education  
Average schooling years in the total population over 25 Barro & Lee (2000) 
Net secondary enrollment rate (% children of secondary 
school age that are currently enrolled in secondary 
school) WDI (2008) 
Health  
Crude death rate (number of deaths per 1,000 population 
/1,000) WDI (2008) 
Life expectancy at birth (years) WDI (2008) 
Infant mortality rate (number of deaths per 1,000 live 
birth/1,000) WDI (2008) 
Income  
GDP per capita in 2000 constant dollars WDI (2008) 
GDP per capita in 1985 international price Barro & Lee (2000) 
Country Specific Variables  
Openness (% GDP from imports and exports) WDI (2008) 
Investment (% GDP used for investment) WDI (2008) 
HIV/AIDS  
HIV prevalence rate (%) 
CIA (2007): The World 
Factbook  
Male Circumcision  
Male circumcision rate (share of male in the country that 
have been circumcised) Wecker et al (2006) 
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Table 2. Panel Regression of Health on Schooling Years 
I. Regression Results 
Dependent variable: Average schooling years 
in the total population over age 25 in year 
85,90, 95 and 99 (a) (b) (c ) 
Average schooling years in the total population 
over age 25 in year 60,65,70 and 75 
-0.046 
(0.057) 
-0.082 
(0.050) 
-0.032 
(0.056) 
Log (infant mortality rate in year 60,65, 70 and 
75) 
-2.558*** 
(0.324)    
Log (life expectancy in year 60,65,70,and 75)  
2.456*** 
(0.215)   
Log (crude death rate in year 60,67,70 and 75)   
-2.40*** 
(0.527) 
Log (GDP per capita in year 60,65,70 and 75) 
0.730*** 
(0.126) 
0.011 
(0.092) 
1.488*** 
(0.344) 
Interaction between log(health indicator) 
 and log (GDP per capita) 
0.243*** 
(0.035) 
-0.017* 
(0.009) 
0.251*** 
(0.072) 
Log (% openness) 
-0.124*** 
(0.047) 
-0.092** 
(0.041) 
-0.085* 
(0.045) 
Log (% investment) 
0.023 
(0.034) 
0.031 
(0.029) 
0.004 
(0.033) 
Constant 
-5.44*** 
(0.807) 
-8.47*** 
(0.856) 
-
11.528*** 
(2.454) 
# obs 225 220 240 
Countries  89 86 91 
F-statistic 37 58 38 
R-sq: within 0.630 0.731 0.617 
Between:  0.723 0.716 0.682 
Overall 0.711 0.71 0.668 
Notes: The numbers in parentheses are standard errors. 
*** p<0.01, ** p<0.05, * p<0.1 
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II. Summary Statistics 
  (a) (b) (c ) 
Average schooling years in the total 
population over age 25  
5.595 
(2.836) 
5.517 
(2.866) 
5.662 
(2.823) 
Average schooling years in the total 
population over age 25, 25 years ago 
3.625 
(2.573) 
3.587 
(2.627) 
3.697 
(2.578) 
Infant mortality 25 years ago 
0.088 
(0.055) 
   
Life expectancy 25 years ago 
  
57.380 
(11.424) 
  
Crude death rate 25 years ago 
   
0.014 
(0.006) 
GDP per capita 25 years ago 
3200.296 
(2914.735) 
3200.341 
(2976.803) 
3240.383 
(2895.797) 
Openness 
58.337 
(87.174) 
58.863 
(89.396) 
60.302 
(87.935) 
Investment 
17.791 
(12.724) 
17.692 
(12.902) 
17.800 
(12.674) 
# obs 233 220 240 
 
Notes: The numbers shown are means of the variables for each regression.  
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Table 3. Panel Regression of Health on GDP Per Capita Growth Rate(Fixed 
Effects) 
I. Regression Results 
Dependent Variable: log (GDP per capita growth 
rate of each of the 25-year periods: 60-85, 65-
90,70-95,75-00, 80-05)  (a)      (b) (c ) 
Log (Secondary net enrollment rate at the 
beginning of the period) 
-0.099*** 
(0.023) 
-0.118 
(0.027) 
-0.086*** 
(0.025) 
Log (infant mortality rate at the beginning of the 
period) 
-1.184 *** 
(0.157)    
Log (life expectancy at birth at the beginning of 
the period)   
0.703 
(0.557)   
Log (crude death rate at the beginning of the 
period)    
-0.931*** 
(0.236) 
Log (GDP per capita at the beginning of the 
period) 
-0.685 *** 
(0.072) 
-1.19** 
(0.419) 
-0.296* 
(0.166) 
Interaction between log(health) and log(GDP per 
capita) 
0.078 *** 
(0.016) 
0.121 
(0.096) 
0.075** 
(0.034) 
Log (openness at the beginning of the period) 
0.026 
(0.036) 
0.105*** 
(0.037) 
0.120*** 
(0.038) 
Log (investment at the beginning of the period) 
0.007 
(0.028) 
-0.028 
(0.027) 
-0.043* 
(0.027) 
Constant 
3.918 *** 
(0.482) 
2.65 
(2.415) 
0.819 
(1.103) 
# obs 404 438 437 
Countries  104 106 105 
F-statistic 65 53 52 
R-sq: within 0.57 0.49 0.49 
Between:  0.01 0.02 0.03 
Overall 0.01 0.01 0.03 
Notes: The numbers in parentheses are standard errors.  
*** p<0.01, ** p<0.05, * p<0.1 
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II. Summary Statistics 
  (a) (b) (c ) 
 GDP per capita growth rate of each of the 
25-year periods: 60-85, 65-90,70-95,75-
00, 80-05  
1.591 
(0.942) 
1.592  
(0.964) 
1.593 
(0.965) 
Secondary net enrollment rate at the 
beginning of the period  
34.440 
(28.786) 
34.858 
(28.661) 
34.883 
(28.685) 
Infant mortality rate at the beginning of 
the period  
58.157 
(11.567)  
Life expectancy at birth at the beginning 
of the period  
0.085 
(0.055)   
Crude death rate at the beginning of the 
period    
0.014 
(0.006) 
GDP per capita at the beginning of the 
period  
4162.74 
(6002.69) 
4113.79 
(5910.98) 
4121.46 
(5914.68) 
# obs 404 438 437 
Notes: The numbers shown are means of the variables for each regression. Also shown in 
parentheses are standard errors. 
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Table 4. Panel Regression of HIV Prevalence on Life Expectancy 
I. Primary Regression 
 Dependent variable: 
Life expectancy in 1980,85,90,95,00 and 05 
OLS (fixed 
effects) 
 
IV (fixed 
effects) 
IV 
(random 
effects) 
HIV*1990 
-0.042 
(0.063) 
-0.294 
(0.109) 
-0.339 
(0.125) 
HIV*1995 
-0.202 
(0.063) -0.546 (0.109) 
-0.591 
(0.125) 
HIV*2000 
-0.596 
(0.063) 
-0.850 
(0.109) 
-0.895 
(0.125) 
HIV*2004 
-0.774 
(0.063) 
-1.024 
(0.109) 
-1.070 
(0.125) 
Life expectancy at birth in 1980 *year Yes Yes Yes 
GDP per capita in 1980 *year Yes Yes Yes 
Youth illiteracy rate in 1980 *year Yes Yes Yes 
# obs 222 222 222 
# countries 37 37 37 
First stage F-statistic --- 29.15 23.64 
F-statistic 23.71 15.69 11.89 
Notes: The numbers in parentheses are standard errors. Bold numbers indicate that we fail to 
reject the null hypothesis at significance level of 0.05.  
 
II. First Stage 
Dependent variable: HIV prevalence rate (CIA) OLS cross-sectional regression 
Circumcision rate (Werker et al 2006) 
-20.840                                
(3.658) 
F-statistics of circumcision rate 32.46 
P(>F) 0 
# obs 37 
R-square 0.481 
 
III. Summary Statistics 
Variables # obs Mean Std. Dev. Min Max 
life expectancy at birth in 1980  37 50.919 6.193 39 62 
HIV prevalence rate 37 8.365 10.36 1 38.8 
Youth illiteracy rate in 1980  37 45.353 20.624 13.8 88.5 
GDP per capita in 1980  37 755.703 936.57 135 4717 
Circumcision rate  37 0.611 0.345 0 1 
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Table 5. Countries Included in Each Regression 
Panel regressions of education on health 
(a)  Algeria, Argentina, Australia, Austria, Bangladesh, Belgium, Benin, Bolivia, 
Botswana, Brazil, Cameroon, Canada, Central African Republic, Chile, China, 
Colombia, Congo, Dem. Rep., Congo, Rep., Costa Rica ,Cyprus, Denmark, 
Dominican Republic, Ecuador, Egypt, Arab Rep., El Salvador, Fiji, Finland, 
France, Gambia, Germany, Ghana, Greece, Guatemala, Guyana, Haiti, 
Honduras, Hong Kong, China, Hungary, India, Indonesia, Iran, Islamic Rep., 
Iraq, Ireland, Israel, Italy, Jamaica, Japan, Jordan, Kenya, Korea, Rep., Lesotho, 
Liberia, 
Malawi,Malaysia,Mali,Mauritius,Mexico,Mozambique,Nepal,Netherlands,New 
Zealand, Nicaragua, Niger, Norway, Pakistan, Panama, Papua New Guinea, 
Paraguay, Peru, Philippines, Poland, Portugal, Rwanda, Senegal ,Serbia and 
Montenegro, Sierra Leone, Singapore, South Africa, Spain, Sri Lanka, Sudan, 
Swaziland, Sweden, Switzerland, Syrian Arab Republic, Thailand, Togo, 
Trinidad and Tobago, Tunisia, Turkey, Uganda, United Kingdom, United 
States, Uruguay, Venezuela, RB, Zambia, Zimbabwe 
 
(b) Countries in (a) and Barbados, Malta 
(c) Countries in (b) and Iceland 
Panel regression of growth rate on health 
(a) Albania, Algeria, Angola, Argentina, Australia, Austria, Bahamas, Bahrain, 
Bangladesh, Belgium, Belize, Benin, Bolivia, Botswana, Brazil, Bulgaria, 
Burkina Faso, Burundi, Cameroon, Canada, Central African Republic, Chad, 
Chile, China, Colombia, Comoros, Congo, Dem. Rep., Congo, Rep., Costa 
Rica, Cote d'Ivoire, Denmark, Dominican Republic, Ecuador, El Salvador, 
Estonia, Fiji, Finland, France, Gabon, Gambia, Ghana, Greece, Guatemala, 
Guyana, Haiti, Honduras, Hungary, Iceland, India, Indonesia, Iran, Islamic 
Rep., Ireland,  Israel, Italy, Jamaica, Japan, Jordan, Kenya ,Korea, Rep., Kuwait 
,Latvia, Lesotho, Liberia, Libya, Luxembourg, Madagascar, Malawi, Malaysia, 
Mali, Malta, Mauritania, Mauritius, Mexico, Moldova, Morocco, Mozambique, 
Nepal, Netherlands, New Zealand, Nicaragua, Niger, Nigeria, Norway, Oman, 
Pakistan, Panama, Papua New Guinea, Paraguay, Peru, Philippines, Portugal, 
Romania, Rwanda, Saudi Arabia, Senegal, Sierra Leone, Solomon Islands, 
Spain, Sri Lanka, Sudan, Suriname, Swaziland, Sweden, Switzerland, Syrian 
Arab Republic, Thailand, Togo, Trinidad and Tobago, Tunisia, Turkey, United 
Kingdom, United States, Uruguay, Venezuela, RB, Zambia, Zimbabwe 
(b) Countries in (a), Cyprus, Georgia, and South Africa 
(c) Countries in (b) except for Comoros 
Panel regression of Life expectancy on HIV prevalence 
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Algeria, Benin, Botswana, Burkina Faso, Burundi, Cameroon, Central African Republic, 
Chad, Comoros, Congo, Dem. Rep., Congo, Rep., Cote d'Ivoire, Egypt, Gambia, Ghana, 
Kenya, Lesotho, Liberia, Libya, Madagascar, Malawi, Mali, Mauritania, Morocco, 
Mozambique, Namibia, Niger, Nigeria, Rwanda, Senegal, South Africa, Sudan, 
Swaziland, Togo, Tunisia, Zambia, Zimbabwe 
 
Appendix 1. Derivation of the utility maximization problem  
 
A representative young agent chooses width and depth of his human capital to 
maximize his lifetime utility: 
(A1) 2
,
1 1
m ax ( , , ) log (log ) (log )
1 (1 )yt at m t yt at m tN Q U c c c c E c E cρ ρ= + ++ +    
Where U is the lifetime expected utility, which depends on consumption of three 
periods, respectively denoted by cyt, cat and cot.  N is the width of human capital, or the 
number of knowledge points possessed by the individual through schooling and Q is the 
depth of human capital. ρ  is the discount rate the agent faces. The consumption of each 
period depends on whether technology has occurred in the adult period, and whether the 
agent survives each period.  
)1()1(
bNQ
NQQlQc Eyt −=−= δδ
  
Qlc Aat )1( −=            if he survives and technology occurs. 
Qc at δ=                        if he survives but technology doesn’t occur. 
0=atc                        if he dies at the end of 1st period. 
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The adoption cost, measured by adoption time, Al , is assumed to be proportional to the 
distance between the occurring technology and the nearest knowledge point owned by the 
individual and the depth of technical innovation he adopts.  
1(1 )mtc Qτ= −     if he survives and the technology occurs in the adult period but not 
the mature period. 
2(1 )mtc Qτ= −      if he survives and a new technology occurs in both the adult and 
mature period.  
mtc Qδ=               if he survives but no new technology occurs in his mature period. 
In this case, the current adult generation shares the same human capital with the mature 
generation. 
0m tc =               if he dies at the end of 2nd period. 
The mature agent enjoys higher consumption if she adopts technology in her adult 
period than otherwise. In other words, the spillover effect is assumed to be relatively small. 
The specifications imply that the level of the human capital of the current adults in the society 
determine the level of the human capital stock. 
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Where p denotes the probability of technological advance, S stands for the scope of 
technological space where the technology occurs randomly following a uniform distribution.   
The expected utility of the mature agent is the probability of living to the mature period 
multiplied by the sum of the expected utility under the different scenarios when technical 
change occurs or doesn’t occur in his adult period or mature period, that is: 
1
2
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Following Kim and Lee (1999), we assume that the utility of the second period with the 
technology adoption is always higher than that without it so that the adoption of the new 
technology is always certain. The first period maximization problem is: 
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As long as p (1-Py) is not zero, the individual expected utility would always be higher if 
he adopts technology when it occurs given the assumption above, therefore, an interior 
solution is guaranteed. The first order conditions are: 
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Multiplying both sides of (A4) by N, and both sides of (A5) by Q, and subtracting (A4) 
from (A5) yields:  
(A6)      (3+k)(z-1) =2logz     Where N
aSQ
z
2
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z is a linear function of the ratio of depth to width. Note that k=0 if P* =0, and k 
increases as P* increases given the discount rate, where P* is the conditional probability of 
surviving up to three periods if the agent survives the young period. Hence k can be 
interpreted as a time value coefficient of future consumption under uncertainty of life 
expectancy. Equation (A6) thus shows a relationship between the probability of premature 
death and the optimal depth-width ratio of human capital investment. When k=0, the equation 
is zz log)1(2/3 =− , as found by Kim and Lee (1999). The addition of a positive k is the result 
of adding a third period into the model. Since aSQ/2N is by definition not zero, 1≠z . It is 
easy to see that for each definite value of k in [0,1], there exists a unique solution for z 
between (0,1) that satisfies equation (A6) since the left hand side can be depicted as a straight 
line through (1,0) and (0, 3+k/2) and the right hand side is a usual log curve through (1,0).  
An analytical solution of equation (A6) is not available since it is non-linear. Using 
simple computer simulation (EXCEL), we can solve for z. Let z* be the equilibrium z that 
satisfies equation (A6). Then, z* gives the equilibrium ratio of depth to width given the 
characteristic space of the innovation that has occurred. The simulation shows that z* 
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declines as k increases, and z* is between [0.421, 0.2]. Therefore, as P* increases, i.e., as 
one is more likely to have a longer life, the optimal ratio of depth to width of human capital 
acquisition increases. The result is expected since in the mature period, the agent is assumed 
to adopt no technology at all. We would expect a different result if the agent adopts new 
technology when mature.  
Then 2(1 *)( 7) Q ZA
N aS
−
=  
Hence, the optimal ratio of depth to width decreases if the uncertainty about the 
characteristic of the technological advance increases. From (A4), (A6), and (A7), we can 
solve for Q and N as: 
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